Estudo randomizado | Enoxaparina (40 mg/dia) é superior à aspirina (100 mg/dia) para prevenção de tromboembolismo em pacientes submetidos a artroplastia de quadril ou joelho.

Effect of Aspirin vs Enoxaparin on Symptomatic Venous Thromboembolism in Patients Undergoing Hip or Knee Arthroplasty: The CRISTAL Randomized Trial – JAMA (gratuito por tempo limitado)

Editorial: Thromboprophylaxis After Hip or Knee Arthroplasty – JAMA

Comentário no Twitter

In patients undergoing hip or knee arthroplasty for osteoarthritis, aspirin compared with enoxaparin resulted in a significantly higher rate of symptomatic venous thromboembolism (VTE), including below-knee VTE. #Research https://t.co/CdlbAgBttJ

— JAMA (@JAMA_current) August 23, 2022